Low-molecular-weight heparins and cancer: focus on antitumoral effect

Annals of Medicine
Massimo Franchini, Pier Mannuccio Mannucci

Abstract

A close relationship between cancer and thrombosis does exist, documented by the fact that an overall 7-fold increased risk of venous thromboembolism (VTE) has been reported in patients with malignancy compared to non-malignancy. The potential impact of antithrombotic agents in cancer-associated VTE has long been recognized, and, in particular, several clinical trials in the last 20 years have reported the safety and efficacy of low-molecular-weight heparins (LMWHs) for treatment and prophylaxis of VTE in patients with various types of cancer. More recently, a number of preclinical and clinical studies have suggested that LMWHs may improve survival in cancer patients with mechanisms that are different from its antithrombotic effect but are linked to the ability of influencing directly the tumor biology. This paper reviews the evidence around the potential survival benefits of LMWHs by analyzing the suggested mechanisms and the available clinical data.

References

Oct 15, 1992·The New England Journal of Medicine·P PrandoniJ W ten Cate
Dec 16, 2000·The New England Journal of Medicine·H T SørensenJ A Baron
Jun 1, 2002·Archives of Internal Medicine·John A HeitL Joseph Melton
Jul 11, 2003·The New England Journal of Medicine·Agnes Y Y LeeUNKNOWN Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
Aug 28, 2003·Journal of Thrombosis and Haemostasis : JTH·A AmirkhosraviJ L Francis
Sep 5, 2003·International Journal of Colorectal Disease·M ProssH-U Schulz
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ajay K KakkarRobin C N Williamson
Nov 16, 2004·Thrombosis and Haemostasis·Hatem A MousaCheng-Hock Toh
Jan 26, 2005·British Journal of Haematology·Agnes Y Y Lee
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clara P W KlerkHarry R Büller
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer L StevensonAjit Varki
Mar 8, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Klas Norrby
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aditya BardiaMatthew P Goetz
Jun 15, 2006·Mayo Clinic Proceedings·Kostandinos SiderasCharles L Loprinzi
Nov 1, 2006·Critical Reviews in Oncology/hematology·T M H NiersD J Richel
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James R HarveySimi Ali
Apr 6, 2007·Journal of Thrombosis and Haemostasis : JTH·A Lazo-LangnerM A Rodger
Dec 3, 2008·Blood Reviews·Moya S CunninghamJames S O'Donnell
Jan 30, 2009·Pathophysiology of Haemostasis and Thrombosis·Grigoris T GerotziafasIsmail Elalamy
Aug 5, 2009·Thrombosis and Haemostasis·Shaker A Mousa, Lars J Petersen
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederiek F van DoormaalHarry R Buller
Nov 22, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A MaraveyasG Bozas
Jan 26, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Sylvia K HaasUNKNOWN TOPIC Investigators
Feb 9, 2012·Seminars in Thrombosis and Hemostasis·Massimo Franchini, Pier Mannuccio Mannucci
Feb 18, 2012·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN SAVE-ONCO Investigators
Apr 9, 2013·British Journal of Haematology·Sarah J BarsamRoopen Arya
Apr 26, 2013·Thrombosis and Haemostasis·Russell D Hull, Grace Townshend

❮ Previous
Next ❯

Citations

Apr 7, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jennifer M KirsteinAnn F Chambers
Jun 9, 2016·Scientific Reports·Ginés Luengo-GilIrene Martínez-Martínez
Oct 27, 2016·Experimental Hematology·Benjamin Heyman, Yiping Yang
Sep 2, 2016·European Respiratory Review : an Official Journal of the European Respiratory Society·Massimo Franchini, Pier Mannuccio Mannucci
Feb 13, 2016·Oncotarget·Rosi BissingerFlorian Lang
May 27, 2020·Journal of Molecular Recognition : JMR·Aaron G Liebsch, Hermann Schillers
Dec 17, 2015·Pharmacological Reviews·Barbara MulloyClive P Page
Dec 20, 2017·European Heart Journal. Case Reports·Tracy NassifElie Mouhayar
May 20, 2019·IScience·Chakrabhavi Dhananjaya MohanKanchugarakoppal S Rangappa
Mar 6, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Lutan ZhouJinhua Zhao
Sep 1, 2021·Seminars in Thrombosis and Hemostasis·Massimo FranchiniAntonio Coppola

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved